HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of nicotinic acid administration on serum levels of bilirubin and iron in patients with porphyria cutanea tarda.

Abstract
Nicotinic acid (NA) administration in Gilbert's syndrome (GS) patients promotes an increment of bilirubin and of total iron serum levels, dependent on a defective hepatic bilitranslocase function and on a haemolytic effect of NA. In porphyria cutanea tarda (PCT): (1) the effect of nicotinic acid on bilirubinaemia is superimposable to that in controls; (2) a well documented disturbance of iron metabolism occurs; (3) but relationship between bilirubin and iron under NA load has never been investigated. The administration of 5.9 mumol/kg body weight of NA to 12 PCT patients, 10 GS subjects and nine healthy volunteers of comparable age resulted in: (1) normal behaviour of bilirubin parameters in PCT but higher bilirubinaemic values in GS subjects; (2) normal values of serum iron in GS subjects, but higher baseline values and lower sideraemic effect of nicotinic acid in PCT patients; (3) a normal NA half-life in PCT and enhanced in GS subjects. These findings confirm a defective bilirubin uptake and excretion by the liver of GS subjects with a normal iron metabolism. On the contrary, in our PCT patients a normal clearance of bilirubin occurs, but a complex disturbance of iron metabolism is well evident in baseline conditions as well as after NA administration. The latter being probably the consequence of an enhanced excretion of iron extraproduced by the haemolytic effect of NA.
AuthorsS Gentile, F Ayala, C Orlando, P Santoianni, G Budillon
JournalScandinavian journal of clinical and laboratory investigation (Scand J Clin Lab Invest) Vol. 48 Issue 7 Pg. 641-5 (Nov 1988) ISSN: 0036-5513 [Print] England
PMID3201096 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nicotinic Acids
  • Iron
  • Bilirubin
Topics
  • Adult
  • Bilirubin (blood)
  • Female
  • Gilbert Disease (blood)
  • Humans
  • Hyperbilirubinemia, Hereditary (blood)
  • Iron (blood)
  • Male
  • Middle Aged
  • Nicotinic Acids (administration & dosage)
  • Porphyrias (blood)
  • Skin Diseases (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: